These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 34362461)

  • 1. Informed consent and informed intervention: SARS-CoV-2 vaccinations not just call for disclosure of newly emerging safety data but also for hypothesis generation and testing.
    Fischer JC; Schmidt AG; Bölke E; Keitel V; Feldt T; Jensen B; Freise NF; Häussinger D; Schneider EM; Hermsen D; Kindgen-Milles D; Knoefel WT; Haussmann J; Tamaskovics B; Plettenberg C; Scheckenbach K; Corradini S; Rox J; Balz V; Maas K; Schmidt L; Grebe O; Ehrhardt A; Gerber PA; Peiper M; Buhren BA; Lichtenberg A; Rezazadeh A; Budach W; Matuschek C
    Eur J Med Res; 2021 Aug; 26(1):87. PubMed ID: 34362461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The Saga of Vaccines against Covid-19].
    Saliou P
    Bull Soc Pathol Exot; 2020; 113(4):185-186. PubMed ID: 33826275
    [No Abstract]   [Full Text] [Related]  

  • 3. Potential effects of vaccinations on the prevention of COVID-19: rationale, clinical evidence, risks, and public health considerations.
    Sultana J; Mazzaglia G; Luxi N; Cancellieri A; Capuano A; Ferrajolo C; de Waure C; Ferlazzo G; Trifirò G
    Expert Rev Vaccines; 2020 Oct; 19(10):919-936. PubMed ID: 32940090
    [No Abstract]   [Full Text] [Related]  

  • 4. Bilateral Acute Macular Neuroretinopathy After Vaccination Against SARS-CoV-2.
    Book BAJ; Schmidt B; Foerster AMH
    JAMA Ophthalmol; 2021 Jul; 139(7):e212471. PubMed ID: 34287612
    [No Abstract]   [Full Text] [Related]  

  • 5. [Vaccination against SARS-CoV-2 in patients with multiple sclerosis].
    Costa Frossard-França L; García-Domínguez JM; Moreno-Torres I; Fortún J; Villar LM; Meca-Lallana V
    Rev Neurol; 2021 Apr; 72(7):250-260. PubMed ID: 33764494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2-specific T cell immunity to structural proteins in inactivated COVID-19 vaccine recipients.
    Deng Y; Li Y; Yang R; Tan W
    Cell Mol Immunol; 2021 Aug; 18(8):2040-2041. PubMed ID: 34267334
    [No Abstract]   [Full Text] [Related]  

  • 7. Next-generation COVID-19 vaccines: Opportunities for vaccine development and challenges in tackling COVID-19.
    Li Q; Wang J; Tang Y; Lu H
    Drug Discov Ther; 2021; 15(3):118-123. PubMed ID: 34234059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The issues of individualized medicine and pharmacovigilance: A consideration of COVID-19 and vaccination.
    Ralph Edwards I; Lindquist M
    Int J Risk Saf Med; 2020; 31(4):179-180. PubMed ID: 33164947
    [No Abstract]   [Full Text] [Related]  

  • 9. The immunology of SARS-CoV-2 infection, the potential antibody based treatments and vaccination strategies.
    Payandeh Z; Mohammadkhani N; Nabi Afjadi M; Khalili S; Rajabibazl M; Houjaghani Z; Dadkhah M
    Expert Rev Anti Infect Ther; 2021 Jul; 19(7):899-910. PubMed ID: 33307883
    [No Abstract]   [Full Text] [Related]  

  • 10. SARS-CoV-2 vaccines for all but a single dose for COVID-19 survivors.
    Frieman M; Harris AD; Herati RS; Krammer F; Mantovani A; Rescigno M; Sajadi MM; Simon V
    EBioMedicine; 2021 Jun; 68():103401. PubMed ID: 34051441
    [No Abstract]   [Full Text] [Related]  

  • 11. India begins COVID-19 vaccination amid trial allegations.
    Bhuyan A
    Lancet; 2021 Jan; 397(10271):264. PubMed ID: 33485435
    [No Abstract]   [Full Text] [Related]  

  • 12. [COVID-19: Would compulsory vaccination be legally possible?].
    Frielitz FS; Wagner IV; Schewe DM; Bothe K
    Dtsch Med Wochenschr; 2021 Feb; 146(3):206-208. PubMed ID: 33440433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. UK science advisers: publish evidence behind COVID vaccine changes.
    Nature; 2021 Jan; 589(7841):169-170. PubMed ID: 33437064
    [No Abstract]   [Full Text] [Related]  

  • 14. COVID-19 vaccines and vaccination program for aging adults.
    Chakraborty C; Sharma AR; Bhattacharya M; Agoramoorthy G; Lee SS
    Eur Rev Med Pharmacol Sci; 2021 Nov; 25(21):6719-6730. PubMed ID: 34787877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetics and biological characteristics of humoral response developing after SARS-CoV-2 infection: implications for vaccination.
    Lippi G; Sciacovelli L; Trenti T; Plebani M;
    Clin Chem Lab Med; 2021 Jul; 59(8):1333-1335. PubMed ID: 33578505
    [No Abstract]   [Full Text] [Related]  

  • 16. Individual preferences for COVID-19 vaccination in China.
    Leng A; Maitland E; Wang S; Nicholas S; Liu R; Wang J
    Vaccine; 2021 Jan; 39(2):247-254. PubMed ID: 33328140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebral venous thrombosis post BNT162b2 mRNA SARS-CoV-2 vaccination: A black swan event.
    Fan BE; Shen JY; Lim XR; Tu TM; Chang CCR; Khin HSW; Koh JS; Rao JP; Lau SL; Tan GB; Chia YW; Tay KY; Hameed S; Umapathi T; Ong KH; Prasad BMRV
    Am J Hematol; 2021 Sep; 96(9):E357-E361. PubMed ID: 34133027
    [No Abstract]   [Full Text] [Related]  

  • 18. COVID vaccines and breastfeeding: what the data say.
    Hall S
    Nature; 2021 Jun; 594(7864):492-494. PubMed ID: 34163051
    [No Abstract]   [Full Text] [Related]  

  • 19. Comprehensive assessment of humoral response after Pfizer BNT162b2 mRNA Covid-19 vaccination: a three-case series.
    Danese E; Montagnana M; Salvagno GL; Peserico D; Pighi L; De Nitto S; Henry BM; Porru S; Lippi G
    Clin Chem Lab Med; 2021 Aug; 59(9):1585-1591. PubMed ID: 33838087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Vaccination immunology in SARS-CoV-2].
    Helweg-Larsen J; Benfield T
    Ugeskr Laeger; 2021 Mar; 183(11):. PubMed ID: 33734074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.